We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXK:NYSEEndeavour Silver Corporation Analysis

Data as of 2026-09-23 - not real-time

$9.24

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Endeavour Silver Corp. trades at $9.23, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 9.8%. With RSI at 40.2 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $9.14 up to resistance at $11.65.
The shares look fair at 44.0 times earnings, though no sector average was available for comparison. Analyst price targets sit 67.8% above the current price. Revenue is growing at 139.4% on a 8.9% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 72.8%, a beta of 2.90 and a maximum drawdown of 47.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

VANCOUVER, British Columbia, Aug. 23, 2026 GLOBE NEWSWIRE -- Endeavour Silver Corp. “Endeavour” or the...Die Endeavour-Silver-Aktie steht nach einer neuen Kreditlinie ueber 25 Mio.Endeavour Silver stock traded at USD 10.51 on September 22, 2026, up 3.75 percent. Guanacevi through

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 9.94
  • MACD momentum is negative
  • 30-day price change of -9.8%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 9.94
  • Analyst targets imply +67.8% versus the current price
  • 30-day volatility of 72.8%

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +67.8% versus the current price
  • Revenue growth of +139.4%
  • P/E ratio of 44.0

Key Metrics & Analysis

Financial Health

Revenue Growth139.40%
Profit Margin8.91%
P/E Ratio44.0
ROE10.58%
ROA10.13%
Debt/Equity34.84
P/B Ratio3.8
Op. Cash Flow$103.1M
Free Cash Flow$67.7M

Technical Analysis

TrendNeutral
RSI40.2
Support$9.14
Resistance$11.65
MA 20$10.52
MA 50$9.57
MA 200$9.94
MACDBearish
VolumeDecreasing
Fear & Greed Index94.39

Valuation

Fair Value$7.65
Target Price$15.50
Upside/Downside67.84%
GradeFair
TypeGrowth

Risk Assessment

Beta2.90
Volatility72.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.